Apyx Medical study links Renuvion to elastin gains in skin

Go back to Apyx Medical study links Renuvion to elastin gains in skin

Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality

September 29, 2026 8:01 AM EDT

CLEARWATER, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (Apyx Medical or the Company), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System (AYON), today announced results from a prospective clinical study evaluating the effects of Renuvion helium plasma radiofrequency technology on biological markers of skin quality. The study was published in Plastic and Reconstructive SurgeryGlobal Open 1.

The study provides new human tissue evidence indicating that Renuvion treatment may produce measurable changes beneath the surface of the skin... More